Article

What We're Reading: States to Recalibrate Hospital Payments; Mumps Outbreak; Tuberculosis Eradication Plan

Author(s):

Some states are rethinking how to compensate hospitals for services, using Medicare reimbursement rates as a benchmark to control costs for state employee health plans; reported cases of mumps are on the rise at Temple University in Philadelphia; the Lancet Commission outlines a new plan for worldwide tuberculosis eradication.

States Use Medicare Reimbursement Rates as a Benchmark to Redesign How Hospitals Are Compensated for Services

States are making efforts to control the costs of state employee health plans by using Medicare reimbursement rates to redesign how they pay hospitals, reported Kaiser Health News. As an example, Dale Folwell, state treasurer of North Carolina, plans to start paying hospitals Medicare rates plus 82%, which he believes will provide hospitals with a modest profit margin while saving the state an estimated $258 million annually. Traditionally, employers or insurers negotiate behind the scenes with hospitals to request discounts to set prices that continue to rise annually and are usually many times higher than the actual cost. Hospital associations opposing the proposition warn of dire consequences, including that hospital revenues could dramatically fall and cause rural hospitals to close.

Cases of Mumps Rising at Temple University

Health officials in Philadelphia now believe 74 individuals have contracted mumps at Temple University, according to the Associated Press. Laboratory testing has confirmed 15 cases, whereas 59 are considered likely due to reported symptoms. The measles, mumps, and rubella vaccine has been recommended by the CDC to prevent the spread of the infection, but research suggests that its effectiveness fades 10 or more years after a second dose is administered. Mumps is a contagious viral infection that causes swollen glands.

Lancet Commission Unveils Plan to End Tuberculosis

The Lancet Commission on tuberculosis proposed a new set of tactics to eradicate the respiratory disease within a generation, STAT News reported. The plan includes investments in rapid diagnostics, vaccine development, and treatment for high-risk populations. These strategies come with a steep price tag as they are predicted to cost an additional $5 billion per year, which would nearly double current international funding to combat the disease. Tuberculosis is responsible for about 4500 deaths per day and is the most deadly infectious disease.

Related Videos
dr ian neeland
dr manisha jhamb
dr john m. o'brien
Ali Khawar
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Carrie Kozlowski
Carrie Kozlowski, OT, MBA
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo